Innovative photoplethysmography technology for rapid non-invasive assessment of peripheral arterial disease in primary care (NOTEPAD)
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 250
Study Overview
Brief Summary
2020 Interim results article in https://pubmed.ncbi.nlm.nih.gov/32959726/ substudy results (added 23/09/2020) 2021 Interim results article in https://doi.org/10.1177/0003319720984882 (added 24/10/2022) 2019 Interim results article in https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-019-4477-3 (added 24/10/2022) 2019 Interim results article in https://link.springer.com/article/10.1007/s41669-019-0135-2 (added 24/10/2022) 2018 Interim results article in https://doi.org/10.3390/diseases6030081 (added 24/10/2022) 2015 Interim results article in https://doi.org/10.3399/bjgp15X685489 Background paper (added 24/10/2022) 2019 Interim results article in https://doi.org/10.3399/bjgpopen19X101659 Qualitative study (added 24/10/2022) 2019 Interim results article in https://doi.org/10.1371/journal.pone.0224546 Qualitative study (added 24/10/2022) 2018 Interim results article in https://doi.org/10.1155/2018/6812404 Signal processing approach (added 24/10/2022) 2020 Interim results article in https://doi.org/10.3389/fdgth.2020.619692 Sub study (added 24/10/2022) 2018 Interim results article in https://link.springer.com/article/10.1007/s41669-018-0076-1 Systematic review (added 24/10/2022) 2022 Results article in https://doi.org/10.1016/j.ejvs.2022.04.013 (added 24/10/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35980897/ Main results (added 24/10/2022)
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Aged 45 years and over
- •2. Provision of informed consent
- •3. Diagnosed with PAD
- •1. Aged 45 years and over
- •2. Provision of informed consent
- •3. Not diagnosed with PAD
Exclusion Criteria
- •1. Those under 45 years of age
- •2. Those unable to provide informed consent.
- •3. Individuals with renal failure receiving renal support therapy (ESRF)
- •4. Patients with tender or painful calves, ankles or feet who would be unable to tolerate ABPI measurements (ulcerated legs)
- •5. Toe/limb amputees (bilateral comparisons needed to make pulse and pressure-based assessments)
- •6. PPG measurement site (big toe pad, index finger pad, earlobe) having any visible damage to local skin area (skin needs to be intact)
- •7. Significant limb tremor
- •8. Patients unable to understand English sufficiently to give informed consent